世界の医療大麻市場

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2021年08月

世界の医療大麻市場 : 製品形態（粉末、固形物、軟膏およびクリーム、油、その他）、誘導体（カンナビジオール、テトラヒドロカンナビノール）、用途（関節炎、がん、アルツハイマー病、その他）、流通経路（小売薬局、オンラインストア、その他）別の動向、成長性、規模分析- 2027年までの予測

Global Medical Cannabis Market Trends, Growth and Size Analysis By Product form (Powders, Solids, Ointments and creams, Oil, Others), By Derivative (Cannabidiol, Tetrahydrocannabinol), By Application (Arthritis, Cancer, Alzheimer’s Disease, Others) and By Distribution Channel (Retail pharmacy, Online stores, Others) – Forecast to 2027

レポート目次　　見積ご依頼・お問合せ　　ご購入案内

Global Medical Cannabis Market– Forecast to 2027

Market Snapshot

As per the MRFR analysis, the global Medical Cannabis Market is expected to register a significant CAGR of 18.14% to surpass USD 33,210.21 million by the end of 2027. Medical marijuana is also called cannabis that has viable remedial properties. The best thing about this plant is that it is used as an unrefined material by various medication associations to make drugs for various medicinal applications. The genuine usage of cannabis for clinical reasons is extending because of its compelling advantages. In any case, it shifts across countries due to the movement, proprietorship, advancement, and clinical finishes paperwork for its use. One more driver of the Medical Cannabis Market is the rising prevalence of continuous contaminations and different illnesses. Clinical Cannabis is ensured and amazing for additional creating signs, for instance, rest issues, pressure, and torture achieved by relentless infections in adults.

The expansion of the Medical Cannabis Market is driven by various elements like augmentation in the usage of cannabis, a rising prevalence of progressing diseases, and considerably more. The growing legitimization of Medical Cannabis in different countries rises to research and improvement of cannabinoids. Nevertheless, growing unlawful usage of Maryjane is depended upon to check the overall Market Outlook advancement. There are various employments of cannabis in the clinical business, which is driving the Medical Cannabis Market development. In the current decade, the use of cannabis has extended even more immediately diverged from various substances. There has been a speedy advancement in cannabis use and is simply climbing in made countries like Western Europe, North America, and Australia.

Segment Overview
The global medical cannabis market is classified into Species, Derivatives, Application, End-use, and route of administration.
Based on species, the market is divided into cannabis Indica, Sativa, and crossbreed.
By derivatives segment, the market has been categorized into cannabidiol (CBD), tetrahydrocannabinol (THC), and much more. In terms of applications, the market has been divided into disease addresses the main classification. By end-use, the market has been classified into the drug business, innovative work communities, and much more. Depending on the route of administration, the market has been divided into oral arrangements and cases, smoking, vaporizers, topical, and others.
Regional Analysis
The Medical Cannabis market has been fragmented dependent on geographics, Asia-Pacific, Americas, Europe, the Middle East, and Africa. The Americas is depended upon to be the greatest market inferable from the rising consumption of clinical cannabis and rising per capita clinical consideration utilization. The market in the Americas has furthermore been stretched out into North America and Latin America, with the North American market divided into the US and Canada. The European Medical Cannabis market has been masterminded in Western Europe and Eastern Europe.
Major Market Players
The major players of the Medical Cannabis market include Canopy Growth, Corporation (Canada), GW Pharmaceuticals PLC (UK), Aurora Cannabis (Canada), Aphria, Inc. (Canada), Maricann Inc. (Canada), Tilray (Canada), Cannabis Sativa Inc. (US), GBSciences Inc. (US), United Cannabis (US), Medical Marijuana, Inc. (US), CanniMed Ltd (Canada), and MediPharm Labs (Canada)

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

目次

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 GROWING R&D ACTIVITIES AND FINANCIAL SUPPORT BY VARIOUS PRIVATE AND GOVERNMENT ORGANIZATIONS

4.2.2 RISING OCCURRENCE OF CHRONIC DISEASES AND OTHER MEDICAL CONDITIONS

4.2.3 LEGALIZATION OF MEDICAL CANNABIS IN VARIOUS REGIONS

4.3 RESTRAINTS

4.3.1 ADVERSE EFFECTS ASSOCIATED WITH CANNABIS

4.3.2 STRINGENT GOVERNMENT POLICIES RELATED TO CBD OIL

4.4 OPPORTUNITIES

4.4.1 IMPROVING STATUS OF CANNABIS IN ASIAN AND AFRICAN COUNTRIES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 PROCUREMENT OF RAW MATERIALS

5.1.2 R&D

5.1.3 MANUFACTURING

5.1.4 DISTRIBUTION AND SALES

5.1.5 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE MEDICAL CANNABIS MARKET

5.3.1 OVERVIEW

5.3.2 IMPACT ON SUPPLY CHAIN

5.3.3 IMPACT ON DEMAND FOR MEDICAL CANNABIS

5.3.4 IMPACT ON EXISTING REGULATIONS

5.3.5 IMPACT ON RESEARCH

5.3.6 IMPACT ON BUYERS AND SUPPLIERS

6 GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 SOLIDS

6.3 DISSOLVABLES/POWDERS

6.4 OIL

6.5 OINTMENTS & CREAMS

7 GLOBAL MEDICAL CANNABIS MARKET, BY DERIVATIVE

7.1 OVERVIEW

7.2 CANNABIDIOL

7.3 TETRAHYDROCANNABINOL

8 GLOBAL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION

8.1 OVERVIEW

8.2 INHALATION

8.3 ORAL

8.4 TOPICAL

9 GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 PAIN MANAGEMENT

9.2.1 NEUROPATHIC PAIN

9.2.2 CANCER

9.2.3 INFLAMMATORY PAIN

9.3 NEUROLOGICAL HEALTH MANAGEMENT

9.3.1 SCLEROSIS

9.3.2 EPILEPSY

9.3.3 ALZHEIMER’S DISEASE

9.3.4 PARKINSON’S DISEASE

9.3.5 OTHERS

9.4 MENTAL HEALTH MANAGEMENT

9.4.1 POST-TRAUMATIC STRESS DISORDER (PTSD)

9.4.2 DEPRESSION

9.4.3 ANXIETY

9.4.4 OTHERS

10 GLOBAL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 HOSPITAL PHARMACY

10.3 RETAIL PHARMACY

10.4 ONLINE PHARMACY

11 GLOBAL MEDICAL CANNABIS MARKET, BY REGION

11.1 OVERVIEW

11.2 AMERICAS

11.2.1 NORTH AMERICA

11.2.1.1 US

11.2.1.2 CANADA

11.2.2 LATIN AMERICA

11.3 EUROPE

11.3.1 WESTERN EUROPE

11.3.1.1 GERMANY

11.3.1.2 FRANCE

11.3.1.3 UK

11.3.1.4 ITALY

11.3.1.5 SPAIN

11.3.1.6 REST OF WESTERN EUROPE

11.3.2 EASTERN EUROPE

11.4 ASIA-PACIFIC

11.4.1 JAPAN

11.4.2 AUSTRALIA

11.4.3 SOUTH KOREA

11.4.4 REST OF ASIA-PACIFIC

11.5 MIDDLE EAST & AFRICA

11.5.1 MIDDLE EAST

11.5.2 AFRICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW

12.2 COMPETITIVE BENCHMARKING

12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL MEDICAL CANNABIS MARKET

12.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MEDICAL CANNABIS MARKET

12.5 KEY DEVELOPMENT ANALYSIS

12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

12.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

12.6.2 MERGER/ACQUISITION

12.6.3 PARTNERSHIP/AGREEMENT

12.6.4 EXPANSION

13 COMPANY PROFILES

13.1 CANOPY GROWTH CORPORATION

13.1.1 COMPANY OVERVIEW

13.1.2 FINANCIAL OVERVIEW

13.1.3 PRODUCTS/SERVICES OFFERED

13.1.4 KEY DEVELOPMENTS

13.1.5 SWOT ANALYSIS

13.1.6 KEY STRATEGIES

13.2 CANNABIS SATIVA, INC.

13.2.1 COMPANY OVERVIEW

13.2.2 FINANCIAL OVERVIEW

13.2.3 PRODUCTS/SERVICES OFFERED

13.2.4 KEY DEVELOPMENTS

13.2.5 SWOT ANALYSIS

13.2.6 KEY STRATEGIES

13.3 GW PHARMACEUTICALS PLC

13.3.1 COMPANY OVERVIEW

13.3.2 FINANCIAL OVERVIEW

13.3.3 PRODUCTS/SERVICES OFFERED

13.3.4 KEY DEVELOPMENTS

13.3.5 SWOT ANALYSIS

13.3.6 KEY STRATEGIES

13.4 EMERALD HEALTH THERAPEUTICS

13.4.1 COMPANY OVERVIEW

13.4.2 FINANCIAL OVERVIEW

13.4.3 PRODUCTS/SERVICES OFFERED

13.4.4 KEY DEVELOPMENTS

13.4.5 SWOT ANALYSIS

13.4.6 KEY STRATEGIES

13.5 TILRAY, INC.

13.5.1 COMPANY OVERVIEW

13.5.2 FINANCIAL OVERVIEW

13.5.3 PRODUCT OFFERINGS

13.5.4 KEY DEVELOPMENTS

13.5.5 SWOT ANALYSIS

13.5.6 KEY STRATEGIES

13.6 AURORA CANNABIS INC.

13.6.1 COMPANY OVERVIEW

13.6.2 FINANCIAL OVERVIEW

13.6.3 PRODUCTS/SERVICES OFFERED

13.6.4 KEY DEVELOPMENTS

13.6.5 SWOT ANALYSIS

13.6.6 KEY STRATEGIES

13.7 CARA THERAPEUTICS

13.7.1 COMPANY OVERVIEW

13.7.2 FINANCIAL OVERVIEW

13.7.3 PRODUCTS/SERVICES OFFERED

13.7.4 KEY DEVELOPMENTS

13.7.5 SWOT ANALYSIS

13.7.6 KEY STRATEGIES

13.8 MEDICAL MARIJUANA, INC.

13.8.1 COMPANY OVERVIEW

13.8.2 FINANCIAL OVERVIEW

13.8.3 PRODUCTS/SERVICES OFFERED

13.8.4 KEY DEVELOPMENTS

13.8.5 SWOT ANALYSIS

13.8.6 KEY STRATEGIES

13.9 GB SCIENCES, INC.

13.9.1 COMPANY OVERVIEW

13.9.2 FINANCIAL OVERVIEW

13.9.3 PRODUCTS/SERVICES OFFERED

13.9.4 KEY DEVELOPMENTS

13.9.5 SWOT ANALYSIS

13.9.6 KEY STRATEGIES

13.10 CANNDOC

13.10.1 COMPANY OVERVIEW

13.10.2 FINANCIAL OVERVIEW

13.10.3 PRODUCTS/SERVICES OFFERED

13.10.4 KEY DEVELOPMENTS

13.10.5 SWOT ANALYSIS

13.10.6 KEY STRATEGIES

14 APPENDIX

14.1 REFERENCES

14.2 RELATED REPORTS
LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 LEGALITY OF MEDICAL CANNABIS, BY REGION:

TABLE 4 GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL MEDICAL CANNABIS MARKET, FOR SOLIDS, BY REGION, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL MEDICAL CANNABIS MARKET, FOR DISSOLVABLES/POWDERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL MEDICAL CANNABIS MARKET, FOR OIL, BY REGION, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL MEDICAL CANNABIS MARKET, FOR OINTMENTS & CREAMS, BY REGION, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL MEDICAL CANNABIS MARKET FOR CANNABIDIOL, BY REGION, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL MEDICAL CANNABIS MARKET, FOR TETRAHYDROCANNABINOL, BY REGION, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 13 GLOBAL MEDICAL CANNABIS MARKET FOR INHALATION, BY REGION, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL MEDICAL CANNABIS MARKET, FOR ORAL, BY REGION, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL MEDICAL CANNABIS MARKET, FOR TOPICAL, BY REGION, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL MEDICAL CANNABIS MARKET FOR PAIN MANAGEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 18 GLOBAL MEDICAL CANNABIS MARKET FOR PAIN MANAGEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 19 GLOBAL MEDICAL CANNABIS MARKET FOR NEUROPATHIC PAIN, BY REGION, 2018–2027 (USD MILLION)

TABLE 20 GLOBAL MEDICAL CANNABIS MARKET FOR CANCER, BY REGION, 2018–2027 (USD MILLION)

TABLE 21 GLOBAL MEDICAL CANNABIS MARKET FOR INFLAMMATORY PAIN, BY REGION, 2018–2027 (USD MILLION)

TABLE 22 GLOBAL MEDICAL CANNABIS MARKET, FOR NEUROLOGICAL HEALTH MANAGEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 23 GLOBAL MEDICAL CANNABIS MARKET, FOR NEUROLOGICAL HEALTH MANAGEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 24 GLOBAL MEDICAL CANNABIS MARKET FOR SCLEROSIS, BY REGION, 2018–2027 (USD MILLION)

TABLE 25 GLOBAL MEDICAL CANNABIS MARKET FOR EPILEPSY, BY REGION, 2018–2027 (USD MILLION)

TABLE 26 GLOBAL MEDICAL CANNABIS MARKET FOR ALZHEIMER’S DISEASE, BY REGION, 2018–2027 (USD MILLION)

TABLE 27 GLOBAL MEDICAL CANNABIS MARKET FOR PARKINSON’S DISEASE, BY REGION, 2018–2027 (USD MILLION)

TABLE 28 GLOBAL MEDICAL CANNABIS MARKET FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 29 GLOBAL MEDICAL CANNABIS MARKET, FOR MENTAL HEALTH MANAGEMENT, BY REGION, 2018–2027 (USD MILLION)

TABLE 30 GLOBAL MEDICAL CANNABIS MARKET, FOR MENTAL HEALTH MANAGEMENT, BY TYPE, 2018–2027 (USD MILLION)

TABLE 31 GLOBAL MEDICAL CANNABIS MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY REGION, 2018–2027 (USD MILLION)

TABLE 32 GLOBAL MEDICAL CANNABIS MARKET FOR DEPRESSION, BY REGION, 2018–2027 (USD MILLION)

TABLE 33 GLOBAL MEDICAL CANNABIS MARKET FOR ANXIETY, BY REGION, 2018–2027 (USD MILLION)

TABLE 34 GLOBAL MEDICAL CANNABIS MARKET FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 35 GLOBAL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 36 GLOBAL MEDICAL CANNABIS MARKET FOR HOSPITAL PHARMACY, BY REGION, 2018–2027 (USD MILLION)

TABLE 37 GLOBAL MEDICAL CANNABIS MARKET, FOR RETAIL PHARMACY, BY REGION, 2018–2027 (USD MILLION)

TABLE 38 GLOBAL MEDICAL CANNABIS MARKET, FOR ONLINE PHARMACY, BY REGION, 2018–2027 (USD MILLION)

TABLE 39 GLOBAL MEDICAL CANNABIS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 40 AMERICAS: MEDICAL CANNABIS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 41 AMERICAS: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 42 AMERICAS: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 43 AMERICAS: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 44 AMERICAS: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 45 AMERICAS: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 46 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 47 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 48 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 49 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 50 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 51 NORTH AMERICA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 52 US: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 53 US: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 54 US: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 55 US: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 56 US: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 57 CANADA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 58 CANADA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 59 CANADA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 60 CANADA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 61 CANADA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 62 LATIN AMERICA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 63 LATIN AMERICA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 64 LATIN AMERICA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 65 LATIN AMERICA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 66 LATIN AMERICA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 67 EUROPE: MEDICAL CANNABIS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 68 EUROPE: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 69 EUROPE: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 70 EUROPE: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 71 EUROPE: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 72 EUROPE: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 73 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 74 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 75 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 76 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 77 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 78 WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 79 GERMANY: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 80 GERMANY: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 81 GERMANY: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 82 GERMANY: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 83 GERMANY: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 84 FRANCE: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 85 FRANCE: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 86 FRANCE: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 87 FRANCE: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 88 FRANCE: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 89 UK: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 90 UK: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 91 UK: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 92 UK: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 93 UK: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 94 ITALY: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 95 ITALY: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 96 ITALY: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 97 ITALY: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 98 ITALY: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 99 SPAIN: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 100 SPAIN: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 101 SPAIN: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 102 SPAIN: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 103 SPAIN: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 104 REST OF WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 105 REST OF WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 106 REST OF WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 107 REST OF WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 108 REST OF WESTERN EUROPE: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 109 EASTERN EUROPE: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 110 EASTERN EUROPE: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 111 EASTERN EUROPE: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 112 EASTERN EUROPE: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 113 EASTERN EUROPE: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 114 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 115 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 116 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 117 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 118 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 119 ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 120 JAPAN: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 121 JAPAN: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 122 JAPAN: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 123 JAPAN: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 124 JAPAN: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 125 AUSTRALIA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 126 AUSTRALIA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 127 AUSTRALIA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 128 AUSTRALIA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 129 AUSTRALIA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 130 SOUTH KOREA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 131 SOUTH KOREA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 132 SOUTH KOREA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 133 SOUTH KOREA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 134 SOUTH KOREA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 135 REST OF ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 136 REST OF ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 137 REST OF ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 138 REST OF ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 139 REST OF ASIA-PACIFIC: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 140 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 141 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 142 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 143 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 144 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 145 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 146 MIDDLE EAST: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 147 MIDDLE EAST: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 148 MIDDLE EAST: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 149 MIDDLE EAST: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 150 MIDDLE EAST: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 151 AFRICA: MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 152 AFRICA: MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2018–2027 (USD MILLION)

TABLE 153 AFRICA: MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2018–2027 (USD MILLION)

TABLE 154 AFRICA: MEDICAL CANNABIS MARKET, BY APPLICATION, 2018–2027 ((USD MILLION)

TABLE 155 AFRICA: MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (USD MILLION)

TABLE 156 MAJOR PLAYERS IN THE GLOBAL MEDICAL CANNABIS MARKET

TABLE 157 MOST ACTIVE PLAYER IN THE GLOBAL MEDICAL CANNABIS MARKET

TABLE 158 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 159 MERGER/ACQUISITION

TABLE 160 PARTNERSHIP/AGREEMENT

TABLE 161 EXPANSION/ INVESTMENT

TABLE 162 CANOPY GROWTH CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 163 CANOPY GROWTH CORPORATION: KEY DEVELOPMENTS

TABLE 164 CANNABIS SATIVA, INC.: PRODUCTS/SERVICES OFFERED

TABLE 165 CANNABIS SATIVA, INC.: KEY DEVELOPMENTS

TABLE 166 GW PHARMACEUTICALS PLC: PRODUCTS/SERVICES OFFERED

TABLE 167 GW PHARMACEUTICALS PLC: KEY DEVELOPMENTS

TABLE 168 EMERALD HEALTH THERAPEUTICS: PRODUCTS/SERVICES OFFERED

TABLE 169 EMERALD HEALTH THERAPEUTICS: KEY DEVELOPMENTS

TABLE 170 TILRAY, INC.: PRODUCT OFFERINGS

TABLE 171 TILRAY, INC.: KEY DEVELOPMENTS

TABLE 172 AURORA CANNABIS INC.: PRODUCTS/SERVICES OFFERED

TABLE 173 AURORA CANNABIS INC.: KEY DEVELOPMENTS

TABLE 174 CARA THERAPEUTICS: PRODUCTS/SERVICES OFFERED

TABLE 175 CARA THERAPEUTICS: KEY DEVELOPMENTS

TABLE 176 MEDICAL MARIJUANA, INC.: PRODUCTS/SERVICES OFFERED

TABLE 177 GB SCIENCES, INC.: PRODUCTS/SERVICES OFFERED

TABLE 178 GB SCIENCES, INC.: KEY DEVELOPMENTS

TABLE 179 CANNDOC: PRODUCTS/SERVICES OFFERED

TABLE 180 CANNDOC: KEY DEVELOPMENTS
LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 MARKET STRUCTURE: GLOBAL MEDICAL CANNABIS MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: MEDICAL CANNABIS MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: MEDICAL CANNABIS MARKET

FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: MEDICAL CANNABIS MARKET

FIGURE 9 IMPACTS OF COVID-19 ON PURCHASING ABILITIES, CANADA, 2020

FIGURE 10 GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL MEDICAL CANNABIS MARKET, BY DERIVATIVE, 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2027 (USD MILLION)

FIGURE 13 GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION)

FIGURE 14 GLOBAL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020 & 2027 (USD MILLION)

FIGURE 15 GLOBAL MEDICAL CANNABIS MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 16 GLOBAL MEDICAL CANNABIS MARKET SHARE (%), BY REGION, 2020

FIGURE 17 AMERICAS: MEDICAL CANNABIS MARKET SHARE, BY REGION 2020 (%)

FIGURE 18 NORTH AMERICA: MEDICAL CANNABIS MARKET SHARE, BY COUNTRY 2020 (%)

FIGURE 19 EUROPE: MEDICAL CANNABIS MARKET SHARE (%), BY REGION, 2020

FIGURE 20 WESTERN EUROPE: MEDICAL CANNABIS MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 21 ASIA-PACIFIC: MEDICAL CANNABIS MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 22 MIDDLE EAST & AFRICA: MEDICAL CANNABIS MARKET SHARE (%), BY REGION, 2020

FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 24 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL MEDICAL CANNABIS MARKET

FIGURE 25 GLOBAL MEDICAL CANNABIS MARKET: COMPETITIVE LANDSCAPE

FIGURE 26 CANOPY GROWTH CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 CANOPY GROWTH CORPORATION: SWOT ANALYSIS

FIGURE 28 CANNABIS SATIVA, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 CANNABIS SATIVA, INC.: SWOT ANALYSIS

FIGURE 30 GW PHARMACEUTICALS PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 GW PHARMACEUTICALS PLC: SWOT ANALYSIS

FIGURE 32 EMERALD HEALTH THERAPEUTICS: SWOT ANALYSIS

FIGURE 33 TILRAY, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 TILRAY, INC.: SWOT ANALYSIS

FIGURE 35 AURORA CANNABIS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 36 AURORA CANNABIS INC.: SWOT ANALYSIS

FIGURE 37 CARA THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 38 CARA THERAPEUTICS: SWOT ANALYSIS

FIGURE 39 MEDICAL MARIJUANA, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 40 MEDICAL MARIJUANA, INC.: SWOT ANALYSIS

FIGURE 41 GB SCIENCES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 42 GB SCIENCES, INC.: SWOT ANALYSIS

FIGURE 43 CANNDOC: SWOT ANALYSIS